VIDEO/AUDIO
Don't Ignore Chest Pain!
Chest Pain Centers 2003
Early Symptoms and Recognition of a Heart Attack
Emergency Department
The Blair Witch Effect
Welcome Message (long)
Welcome Message (short)
Free Health Videos

ARTICLES
Value of the History in Evaluating Patients for Early Myocardial Ischemia in Observation Chest Pain Centers
Time Is Muscle. Sites With A Passion.
Early Heart Attack Care Program Saves Lives, Resources.
True Heart Stories
Reader's Digest
What a Heart Attack Taught Me...
Emotional Roadblocks, Misconceptions...

EHAC SPECIFIC EDUCATIONAL GROUPS

EXPERIENCES
EHAC Moments
Share Your Experience

SUBSCRIBE
Enter your email address below to subscribe to the EHAC Announcement List:

From ACC/AHA Guidelines to Best Practice: Can "Acute MI Report Cards" Save Lives? Measuring Quality of Care for Patients With Cardiovascular Disease

Martha J. Radford, MD
Associate Professor of Medicine (Cardiology)
University of Connecticut School of Medicine
Farmington, CT



Quick Overview
  • Measuring Quality of Care: Pros and Cons
  • The Cooperative Cardiovascular Project
  • Results of the CCP Pilot
  • Measuring Quality of Care: Pros and Cons

    The concept of measuring quality of care is one that often makes physicians uneasy. There is concern that clinical subtleties will not be understood in measurements designed by nonphysicians. There is concern that making quantitative estimates of quality of care will lead to inappropriate ranking of providers based on measures whose precision is not well understood. There is concern that "cost of care" will be used as a surrogate for quality of care.

    Cardiovascular care is under particular scrutiny. Cardiovascular disease is common, and care is often "high tech" and expensive. Current clinical science supports a variety of approaches, and there are limitations with prescribed patterns of care ("cookbook medicine"). However, few would deny that it is important to develop quality measures based on firm scientific evidence that are meaningful to physicians and patients, likely to lead to improvements in the delivery and outcome of care, which can inform future clinical research questions and approaches.

    The Cooperative Cardiovascular Project

    The Cooperative Cardiovascular Project (CCP) is a landmark medical care quality improvement initiative in these regards. It is the first project undertaken by the Health Care Finance Administration (HCFA), which has fiscal and quality oversight for all care provided to Medicare beneficiaries, according to principles of quality improvement outlined in 1992. (1)

    An important aspect of the CCP is that input from the provider community was actively sought throughout the project. The Steering Committee consisted of representatives from all physician groups involved in the care of patients with coronary artery disease. The American College of Cardiology/American Heart Association guidelines for the care of patients with acute myocardial infarction (MI) (2) were used as the basis for designing the quality indicators. Physicians active in the care of patients were involved in designing the clinical logic, in verifying whether the logic correctly identified patients eligible for a given care process, and in analyzing and reporting patterns of care to physicians, hospitals, and the medical literature.

    The CCP Pilot was carried out in four states-Alabama, Connecticut, Iowa, and Wisconsin-from 1992 through 1994. The principles underlying the CCP should reassure physicians:
    1. Clinical information is important for judging quality of care. Claims data are inadequate for process-of-care inquiries. In Connecticut, more than 3,000 inpatient records for Medicare patients with acute MI during 1992 and 1993 were reviewed, and more than 750 clinical data elements were abstracted for each record, including admission history and physical exam, medications, test results, and complications.

    2. Recommendations derived from well-designed clinical research (especially randomized controlled trials) are generalizable. For patients with acute MI, recommendations pertinent to administration of thrombolytic therapy, aspirin, beta blockers, ACE inhibitors, and withholding calcium channel blockers are considered well-grounded in the extensive clinical research. This research has contributed to the decline in mortality following acute MI that has been observed over the last two decades.

    3. For a given intervention, a group of patients "ideal" to receive that intervention can be identified. This ideal group of patients, who have clear-cut indications for intervention and no contraindications, represents an "assay" for process of care. For patients not in the ideal group, who may have a relative contraindication to or an uncertain indication for a given care process, decision making is left up to the physician, with no judgment made about the quality of that decision.
    Computerized records for more than 14,000 primary hospitalizations for Medicare patients with acute MI in Alabama, Connecticut, Iowa, and Wisconsin during June 1992 through February 1993 make up the CCP Pilot data base. Average patient age was 75 years, 54% were male, and 30-day mortality was 19%
    .
    The results of the CCP Pilot have been recently reported, (3) and show that even for patients considered ideal candidates for a given intervention, there is evidence of underutilization of accepted therapies (Table 1).




    In addition, there is opportunity for improvement in the time to administration of thrombolytic therapy. Mean time between hospital arrival and administration was 1.2 hours; only 11% of patients received thrombolytic therapy within 30 minutes of arrival, the current national door-to-drug target.

    As important as these insights to providers are, the CCP Pilot has also demonstrated to the "quality measurers" some important principles:
    1. Cookbook medicine is not possible. The relatively small size of the ideal candidate patient set for some therapies surprised many nonphysicians but did not surprise physicians, who understand how commonly the clinical characteristics of individual patients modulate care decisions, particularly for the elderly. For patients who are not ideal candidates, therapy is left up to physician judgment, as it should be.

    2. It is easier to analyze patterns of care when the process is recommended for virtually all patients. Development of the ideal candidate methodology allowed for analysis of processes of care for generally applicable therapies. However, within a population-based sample such as the CCP records, quality of care for exceptional patients, eg, those with septal rupture after acute MI, cannot be measured in any meaningful way. Care of these far-from-average patients is an important-and as yet unmeasurable-component of the quality of care of a medical care system.
    The CCP Pilot has demonstrated that some aspects of the quality of medical care can be measured, and that there is opportunity for improvement in the delivery of commonly accepted therapies. The CCP is now a national project, with measurement of quality of care as developed in the Pilot being applied to hospitals in all 50 states. In fact, the four CCP Pilot states will be the first to be "assayed" twice. Records from acute MI admissions in late 1995 in the four pilot states will be examined to see whether there has been any increase in the utilization of the therapies under examination and whether improvement in quality of care can be discerned. When this second inquiry is completed, we will have an answer to the question, can report cards save lives?

    References  

    1. Jencks SF, Wilensky GR. The health care quality improvement initiative: a new approach to quality assurance in Medicare. JAMA. 1992;
    268:900-903.

     2. Gunnar RM, Bourdillon PDV, Dixon DW, et al. Guidelines for the early management of patients with acute myocardial infarction. J Am Coll Cardiol. 1990;6:249-292.

     3. Ellerbeck EF, Jencks SF, Radford MJ, et al. Quality of care for Medicare patients with acute myocardial infarction. JAMA. 1995;273:1509-1514.

    Return to Index of Articles for Clinician; Volume 14.4


    Home | What's New | What is EHAC? | Abstracts & Articles
    Reader's Digest | Contact Us | Search

    Tips for Searching

    www.ehac.org. Site by AllSoldOut Internet Solutions
    Visit the Clinical Information EHAC site at www.chestpaincenters.org.
    Copyright © 1996-2001 by St. Agnes Healthcare. All Rights Reserved.

    ABOUT US
    The Value of Being Prepared
    Time is Muscle
    Funding/Support
    Heart Facts

    A Staggering Discovery

    FROM DR. BAHR
    Dr. Bahr's Introduction to Reader's Digest
    To My Patient and Friend

    MORE INFO
    EHAC Dissemination
    EHAC World Proclamation
    The Chain of Survival
    EHAC Privacy Policy
    Add Our Banner to Your Website
    EHAC Links

    SUBSCRIBE
    Enter your email address below to subscribe to the EHAC Discussion List: